COMPANY
PIRAMAL PHARMA LTD
PIRAMAL PHARMA LTD: API manufacturer for Cetrorelix, Desmopressin, Lanreotide, Leuprolide, Liraglutide, Octreotide, Oxytocin, Semaglutide, Vasopressin, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Cetrorelix | DMF 34552, type II, active, submitted 2020-03-19 Regulator FDA drug master file list |
|---|---|
| Desmopressin | DMF 22871, type II, active, submitted 2009-06-16 Regulator FDA drug master file list |
| Lanreotide | DMF 42310, type II, active, submitted 2025-07-30 Regulator FDA drug master file list |
| Leuprolide | DMF 25128, type II, active, submitted 2011-06-30 Regulator FDA drug master file list |
| Liraglutide | DMF 43839, type II, active, submitted 2026-03-28 Regulator FDA drug master file list |
| Octreotide | DMF 36322, type II, active, submitted 2021-11-16 Regulator FDA drug master file list |
| Oxytocin | DMF 37689, type II, active, submitted 2023-03-06 Regulator FDA drug master file list |
| Semaglutide | DMF 43801, type II, active, submitted 2026-03-13 Regulator FDA drug master file list |
| Vasopressin | DMF 32146, type II, active, submitted 2017-10-12 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.